Doctor Tushar Kotecha

Doctor Tushar Kotecha

Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)

Do the current guidelines define the right treatment for all acute pulmonary embolism patients at risk for cardiogenic shock?

Event: ESC Acute CardioVascular Care 2024

Topic: Pulmonary Embolism (PE)

Session: Bridging the gap between current acute pulmonary embolism patient management and the latest scientific insights

Access

Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia

Event: ESC Congress 2019

Topic: Infiltrative Myocardial Disease

Session: Hot topics in myocardial and pericardial diseases

Access

Quantitative CMR perfusion mapping to detect microvascular dysfunction in patients without obstructive coronary disease

Event: EuroCMR 2019

Topic: Stress Cardiac Magnetic Resonance (CMR)

Session: Rapid Fire Abstract 3: stress CMR: utility in coronary artery disease and beyond

Access

Redefining assessment of adenosine stress response using CMR perfusion mapping: An alternative to splenic switch off

Event: EuroCMR 2019

Topic: Stress Cardiac Magnetic Resonance (CMR)

Session: Rapid Fire Abstract 3: stress CMR: utility in coronary artery disease and beyond

Access

Quantification of myocardial infarct size and microvascular obstruction using dark-blood late gadolinium enhancement

Event: EuroCMR 2019

Topic: Late Gadolinium Enhancement

Session: Moderated ePosters session 2: frontiers in viability imaging

Access

Follow up CMR to track treatment response in cardiac al amyloidosis

Event: EuroCMR 2017

Topic: Cardiac Magnetic Resonance

Session: Case session 1

Access

Persistent circulating platelet and endothelial derived microparticle signature during 6 month follow up of patients undergoing PCI for ACS versus stable angina.

Event: ESC Congress 2016

Topic: Thrombosis and coagulation

Session: Thrombosis and antithrombotic in acute coronary syndrome

Access

The incidence of abnormal ventilation/perfusion SPECT in pulmonary hypertension without chronic thromboembolism

Event: ESC Congress 2016

Topic: Hypertension, other

Session: Chronic pulmonary hypertension

Access

Follow-up haemodynamic assessment as a predictor of survival in scleroderma-associated pulmonary arterial hypertension

Event: ESC Congress 2016

Topic: Chronic pulmonary hypertension

Session: Chronic pulmonary hypertension

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Tushar Kotecha Follow

Contributor content

Do the current guidelines define the right treatment for all acute pulmonary embolism patients at risk for cardiogenic shock?

Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia

Quantitative CMR perfusion mapping to detect microvascular dysfunction in patients without obstructive coronary disease

Redefining assessment of adenosine stress response using CMR perfusion mapping: An alternative to splenic switch off

Quantification of myocardial infarct size and microvascular obstruction using dark-blood late gadolinium enhancement

Follow up CMR to track treatment response in cardiac al amyloidosis

Persistent circulating platelet and endothelial derived microparticle signature during 6 month follow up of patients undergoing PCI for ACS versus stable angina.

The incidence of abnormal ventilation/perfusion SPECT in pulmonary hypertension without chronic thromboembolism

Follow-up haemodynamic assessment as a predictor of survival in scleroderma-associated pulmonary arterial hypertension

ESC 365 is supported by

Doctor Tushar Kotecha